Comments taken from Q2 earnings conference call.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie raises FY25 adjusted EPS view to $11.88-$12.08 from $11.67-$11.87
- AbbVie reports Q2 adjusted EPS $2.97, consensus $2.91
- Options Volatility and Implied Earnings Moves Today, July 31, 2025
- M&A News: AbbVie Eyes $1B Acquisition of Gilgamesh Therapeutics
- Is ABBV Stock (ABBV) a Buy Ahead of Q2 Earnings?